Acer Therapeutics Inc (ACER) is down Tuesday morning, with the stock declining -8.77% in pre-market trading to 1.04. ACER's short-term technical score of 44 indicates that the stock has traded less bullishly over the last month than 56% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, ACER ranks higher than 66% of stocks. Acer Therapeutics Inc has risen 50.00% over the past month, closing at $0.76 on August 8. During this period of time, the stock fell as low as $0.57 and as high as $1.76. ACER has an average analyst recommendation of Strong Buy. The company has an average price target of $9.67.
ACER has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on ACER!